Application of GC–MS in Analytical Method Development for Volatile Drug Substances: A Comprehensive Review
Keywords:
Gas Chromatography–Mass Spectrometry, Volatile Drug Substances, Method Development, Residual Solvent Analysis, Impurity Profiling, Stability Studies, Analytical ValidationAbstract
Gas Chromatography–Mass Spectrometry (GC–MS) is a powerful and widely employed analytical technique for the identification, separation, and quantification of volatile drug substances in pharmaceutical analysis. Volatile compounds, characterized by low molecular weight, high vapor pressure, and low boiling points, require specialised analytical approaches due to their susceptibility to evaporation and degradation. This review highlights the fundamental principles of GC–MS, including gas chromatographic separation and mass spectrometric detection, along with key instrumental components and ionisation techniques such as electron ionisation and chemical ionisation. The article comprehensively discusses method development strategies, emphasising sample preparation techniques such as liquid–liquid extraction, solid-phase extraction, headspace analysis, and solid-phase microextraction. Optimisation of chromatographic conditions and mass spectrometric parameters is also addressed to achieve enhanced sensitivity, resolution, and reproducibility. Method validation based on ICH guidelines ensures the reliability and regulatory compliance of analytical procedures. Furthermore, the review explores diverse applications of GC–MS, including impurity profiling, residual solvent analysis, pharmacokinetic studies, and bioanalysis. Stability studies under thermal, oxidative, and photolytic conditions are discussed, highlighting the role of GC–MS in identifying degradation products. The advantages, limitations, regulatory aspects, recent advancements, and challenges associated with GC–MS are critically evaluated.
References
1. Poole CF. Gas Chromatography. Amsterdam: Elsevier; 2012.
2. Sparkman OD, Penton Z, Kitson FG. Gas Chromatography and Mass Spectrometry: A Practical Guide. 2nd ed. Academic Press; 2011.
3. Grob RL, Barry EF. Modern Practice of Gas Chromatography. 4th ed. Wiley; 2004.
4. International Council for Harmonisation (ICH). Q3C(R6): Impurities: Guideline for Residual Solvents. 2016.
5. Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography. 3rd ed. Wiley; 2010.
6. Kazakevich Y, Lobrutto R. HPLC for Pharmaceutical Scientists. Wiley; 2007.
7. Gross JH. Mass Spectrometry: A Textbook. 3rd ed. Springer; 2017.
8. Snow NH, Slack GC. Head-space analysis in modern gas chromatography. TrAC Trends Anal Chem. 2002;21(9-10):608–617.
9. McNair HM, Miller JM. Basic Gas Chromatography. 2nd ed. Hoboken: Wiley; 2009.
10. de Hoffmann E, Stroobant V. Mass Spectrometry: Principles and Applications. 3rd ed. Chichester: Wiley; 2007.
11. Harris DC. Quantitative Chemical Analysis. 9th ed. New York: W.H. Freeman; 2016.
12. Skoog DA, Holler FJ, Crouch SR. Principles of Instrumental Analysis. 6th ed. Belmont: Cengage Learning; 2007.
13. Watson JT, Sparkman OD. Introduction to Mass Spectrometry: Instrumentation, Applications, and Strategies for Data Interpretation. 4th ed. Chichester: Wiley; 2007.
14. Miller JH, Miller JC. Statistics and Chemometrics for Analytical Chemistry. 6th ed. Harlow: Pearson Education; 2010.
15. Kolb B, Ettre LS. Static Headspace-Gas Chromatography: Theory and Practice. 2nd ed. Hoboken: Wiley; 2006.
16. Pawliszyn J. Handbook of Solid Phase Microextraction. Amsterdam: Elsevier; 2012.
17. European Medicines Agency (EMA). ICH Q3C (R6): Impurities: Guideline for Residual Solvents. London: EMA; 2016.
18. Mondello L, Tranchida PQ, Dugo P, Dugo G. Comprehensive two-dimensional gas chromatography–mass spectrometry: A review. Mass Spectrom Rev. 2008;27(2):101–124.
19. Marriott PJ, Shellie R. Principles and applications of gas chromatography. TrAC Trends Anal Chem. 2002;21(9-10):573–583.
20. Thurman EM, Mills MS. Solid-phase extraction: Principles and practice. J Chromatogr A. 1998;800(1):3–19.
21. Kolb B. Headspace sampling in gas chromatography. J Chromatogr A. 1999;842(1-2):163–205.
22. Kataoka H, Lord HL, Pawliszyn J. Applications of solid-phase microextraction. J Chromatogr A. 2000;880(1-2):35–62.
23. Sandra P, Bicchi C. Capillary gas chromatography in essential oil analysis. J Chromatogr A. 1987;404:175–192.
24. Smith RM. Before the injection—modern sample preparation techniques. J Chromatogr A. 2003;1000(1-2):3–27.
25. Niessen WMA. Current practice of gas chromatography–mass spectrometry. J Chromatogr A. 2003;1000(1-2):413–436.
26. Shrivastava A, Gupta VB. Methods for determination of limit of detection and limit of quantitation. Chron Young Sci. 2011;2(1):21–25.
27. Ermer J, Miller JH. Method Validation in Pharmaceutical Analysis: A Guide to Best Practice. Weinheim: Wiley-VCH; 2005.
28. Borman P, Elder D. Q2(R1) validation of analytical procedures. Pharm Technol. 2017;41(5):48–57.
29. Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies. J Pharm Anal. 2014;4(3):159–165.
30. Narayanan BV, Sreenivas J, Rao VS. Spectrophotometric Determination of Trace Amounts of Molybdenum (VI) Using 3.4-Dihydroxybenzaldehyde Thiosemicarbazone. Research Journal of Chemistry and Environment. 2006;10:67-70.
31. Baertschi SW, Alsante KM, Reed RA. Pharmaceutical Stress Testing: Predicting Drug Degradation. J Pharm Sci. 2011;100(3):692–700.
32. Niessen WMA. Fragmentation of toxicologically relevant compounds in mass spectrometry. J Chromatogr A. 2011;1218(27):4040–4054.
33. Mohan Kk, Patrudu Tb, Burle Gs, Salakolusu S, Raju Pvn, Jonnalagadda Sb, et al. Isolation and structural elucidation of an unknown novel impurity in sulfasalazine by high-performance liquid chromatography coupled to mass spectroscopy and toxicology prediction. Chinese Journal of Analytical Chemistry [Internet]. 2025 Jul 19;53(11):100601.
34. P. Erukulla, P.V.N. Raju, Health Implications of 5G Radiofrequency Exposure on Respiratory Diseases: A Comprehensive Review. J. PharmTechNova. 2026, 01 [01], 23-41.
35. K.T.K. Reddy, G. Surendra, E.J. Mart, R.H. Babu, M.S. Arabath S.A., P. Erukulla, K.V. Kandimalla, P.V.N. Raju, Computational Identification of Natural Product–Based Aryl Hydrocarbon Receptor Modulators for Psoriasis Therapy. Chem. Methodol., 2026, 10(4) 450-464
36. Murali Krishnam Raju P, Shyamala P, Venkata Narayana B, Dantuluri HSNR, Bhupatiraju RV. A fast, validated UPLC method coupled with PDA-QDa detectors for impurity profiling in betamethasone acetate and betamethasone phosphate injectable suspension and isolation, identification, characterization of two thermal impurities. Annales Pharmaceutiques Françaises. 2022 Nov;80(6):837–52.
37. Bhingaradiya S, Dantinapalli VLS, Elumalai S. Stability Indicating Method Development and Validation of Vimseltinib by Using HPLC in Bulk and Pharmaceutical Dosage Form. IJPDA [Internet]. 2026Feb.23 [cited 2026Apr.26];14(1):14-9. Available from:
38. S R, S S, P P, A S. Development and Validation of a Forced Degradation UPLC Method For The Simultaneous Determination of Eplerenone and Torsemide in Bulk and Pharmaceutical Dosage Form. World Journal of Current Medical and Pharmaceutical Research. 2026 Feb 11;
39. Zhang Z, Yang MJ, Pawliszyn J. Solid-phase microextraction in pharmaceutical analysis. Anal Chem. 1994;66(17):844A–853A.
40. Mondello L, Tranchida PQ, Dugo P, Dugo G. Multidimensional chromatography in complex analysis. Mass Spectrom Rev. 2008;27(2):101–124.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
.